Cargando…
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
Alzheimer’s disease (AD) is marked by the presence of amyloid beta (Aβ) plaques, neurofibrillary tangles (NFT), neuronal death and synaptic loss, and inflammation in the brain. AD research has, in large part, been dedicated to the understanding of Aβ and NFT deposition as well as to the pharmacologi...
Autores principales: | Frost, Georgia R., Jonas, Lauren A., Li, Yue-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916654/ https://www.ncbi.nlm.nih.gov/pubmed/31920620 http://dx.doi.org/10.3389/fnagi.2019.00337 |
Ejemplares similares
-
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
por: Qiu, Wei Qiao, et al.
Publicado: (2014) -
Oxygen: both friend and foe
por: Purvis, J
Publicado: (2018) -
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
por: Mayne, Katie, et al.
Publicado: (2020) -
Human Mannose-binding Lectin in Immunity: Friend, Foe, or Both?
por: Casanova, Jean-Laurent, et al.
Publicado: (2004) -
Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)